King Fai Leung
About King Fai Leung
King Fai Leung (age 52) has served as a director of Planet Green Holdings (PLAG) since July 2019. He is the Audit Committee chair and designated audit committee financial expert, with over 20 years of finance and accounting experience, and is a Certified Public Accountant in both Hong Kong and Australia. He holds a Bachelor of Commerce in Accounting and Finance from Deakin University, Australia .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Chineseinvestors.com, Inc. (OTCQB: CIIX) | Independent Director; re-designated Executive Director & CFO | Independent Director since Nov 2017; CFO re-designated Mar 2019 | Finance leadership and oversight |
| Daisho Microline Holdings Ltd. (HKG:0567) | Independent Director; Chairman of Audit Committee; Member of Remuneration & Nomination Committee | Since Jun 2015 | Audit chair; remuneration/nomination oversight |
| Kirin Group Holdings Limited (HKG:8109) | Director | Prior service (dates not disclosed) | Financial-related business oversight |
| Biostar Pharmaceuticals, Inc. (OTC Pink: BSPM) | Director | Prior service (dates not disclosed) | Pharmaceutical governance |
| Hao Wen Holdings Limited (HKG:8019) | Director | Prior service (dates not disclosed) | Biomass fuel sector governance |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Maxima Energy Limited (Hong Kong) | Executive Director | Since Dec 2018 | Energy sector executive role |
Board Governance
- Independence: Board affirmatively determined no material relationships for independent directors; all Audit and Compensation Committee members are independent under NYSE American rules; Leung is independent .
- Committee assignments (FY2024):
- Audit Committee: Leung (Chair, Financial Expert), Yang Cao, Luojie Pu; 4 meetings held .
- Compensation Committee: Chair—Luojie Pu; members—Leung, Yang Cao; 1 meeting held; all members independent; no Item 404 relationships; no interlocks disclosed .
- Nominating & Corporate Governance Committee: Chair—Yang Cao; members—Leung, Luojie Pu; 1 meeting held .
- Board attendance: In FY2024, Board held 12 meetings; each current director attended at least 75% of Board and applicable committee meetings during their service period .
- Clawback policy: Adopted Nov 28, 2023 for executive officers in event of accounting restatement, administered by independent directors/committee .
Fixed Compensation
| Metric | 2023 | 2024 |
|---|---|---|
| Annual cash retainer/salary ($USD) | $21,600 | $21,600 |
| All other cash comp | $0 | $0 |
Notes: Per employment agreement at appointment (July 2019), PLAG is obligated to pay Leung $21,600 per year .
Performance Compensation
| Component | 2023 | 2024 | Vesting/Performance Metrics |
|---|---|---|---|
| Bonus | $0 | $0 | No performance bonus disclosed |
| Stock awards (RSUs/PSUs) | $0 | $0 | No equity grants disclosed |
| Option awards | $0 | $0 | No options disclosed |
No director equity grants, performance metrics, or vesting schedules are disclosed for Leung in FY2023–FY2024 .
Other Directorships & Interlocks
| Company | Market | Role | Committee Roles | Potential Interlock with PLAG |
|---|---|---|---|---|
| Chineseinvestors.com, Inc. | OTCQB: CIIX | Exec Director & CFO (since Mar 2019); prior Independent Director | N/A | None disclosed; PLAG board confirms no material relationships for independent directors |
| Daisho Microline Holdings Ltd. | HKG:0567 | Independent Director | Audit Chair; Remuneration & Nomination member | None disclosed |
| Kirin Group Holdings Limited | HKG:8109 | Director (prior) | N/A | None disclosed |
| Biostar Pharmaceuticals, Inc. | OTC Pink: BSPM | Director (prior) | N/A | None disclosed |
| Hao Wen Holdings Limited | HKG:8019 | Director (prior) | N/A | None disclosed |
| Maxima Energy Limited | Private (HK) | Executive Director | N/A | None disclosed |
- Related-party transactions oversight: Related-person transactions ≥$120,000 are reviewed by the Audit Committee; directors with conflicts recuse; Compensation Committee members reported no Item 404 relationships .
Expertise & Qualifications
- CPA in Hong Kong and Australia; over 20 years finance/accounting experience; B.Comm (Accounting & Finance), Deakin University .
- Designated Audit Committee Financial Expert; chairs PLAG’s Audit Committee .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Class |
|---|---|---|
| King Fai Leung | — (none) | — (not stated) |
- Group ownership: All executive officers, directors, and director nominees as a group (seven individuals) held 1,494,200 shares (20.51%), driven by Bin Zhou; Leung holds none .
Insider Trades
| Date Range | Form | Transaction Type | Shares | Price | Source |
|---|---|---|---|---|---|
| 2019–2025 | Form 4 | No open-market buys/sells recorded for Leung | — | — | Fintel roster shows Leung with 0 shares owned |
| 2025 | 10-K reference | Director roles and compensation; no trades disclosed | — | — | SEC 10-K profile of directors |
Governance Assessment
- Strengths:
- Audit chair and designated financial expert leading financial reporting oversight; Audit Committee met 4 times in FY2024 .
- Independence affirmed; Compensation and Audit Committees fully independent; no Item 404 relationships for Compensation Committee members .
- Board/committee attendance thresholds met; Board held 12 meetings in FY2024; each director attended ≥75% .
- Formal related-party review process and executive clawback policy adopted in 2023 .
- Concerns / RED FLAGS:
- Zero beneficial ownership by Leung suggests limited pay-for-performance alignment via equity; no director equity grants disclosed for 2023–2024 .
- Multiple external executive roles (e.g., CFO at Chineseinvestors.com; Executive Director at Maxima Energy) can pose time/attention constraints; though Board has affirmed independence and no material relationships .
- Watch items:
- Continued verification of any related-party transactions; Audit Committee policy mandates review and recusal where applicable .
- Monitor committee meeting cadence and attendance beyond “≥75%” minimum to ensure robust oversight .